Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Treasury Shares: 2021-2024

Historic Treasury Shares for CureVac N.V (CVAC) over the last 3 years, with Sep 2023 value amounting to -$35,829.

  • CureVac N.V's Treasury Shares rose 54.87% to -$35,829 in Q3 2023 from the same period last year, while for Sep 2023 it was -$35,829, marking a year-over-year increase of 54.87%. This contributed to the annual value of $1.5 million for FY2022, which is 77.29% down from last year.
  • Latest data reveals that CureVac N.V reported Treasury Shares of -$35,829 as of Q3 2023, which was up 0.03% from -$35,840 recorded in Q2 2023.
  • Over the past 5 years, CureVac N.V's Treasury Shares peaked at $6.7 million during Q4 2021, and registered a low of -$3.6 million during Q2 2021.
  • Over the past 3 years, CureVac N.V's median Treasury Shares value was $216,696 (recorded in 2023), while the average stood at $55.1 million.
  • As far as peak fluctuations go, CureVac N.V's Treasury Shares soared by 100.00% in 2022, and later plummeted by 114.14% in 2024.
  • Over the past 3 years, CureVac N.V's Treasury Shares (Quarterly) stood at $6.7 million in 2021, then slumped by 77.29% to $1.5 million in 2022, then soared by 54.87% to -$35,829 in 2023.
  • Its Treasury Shares stands at -$35,829 for Q3 2023, versus -$35,840 for Q2 2023 and -$369,230 for Q1 2023.